民信國際控股(08456.HK)收到中山勞動人事爭議仲裁委員會仲裁法院兩項仲裁裁決
格隆匯 4 月 28日丨民信國際控股(08456.HK)公吿,於2021年4月28日,中山美麗華兒童服裝製品有限公司("美麗華",一間於中華人民共和國("中國")成立的有限公司,為公司的全資附屬公司)收到中山市勞動人事爭議仲裁委員會的仲裁法院分別於2021年4月12日及2021年4月20日作出的兩項仲裁裁決,內容有關200名僱員及86名僱員於仲裁法院就工資及福利賠償向美麗華提起的兩項申索,金額合共分別約人民幣1330萬元及人民幣590萬元。根據仲裁裁決:
1.美麗華須向200名僱員支付賠償,金額合共約人民幣790萬元;及2.美麗華須向86名僱員支付賠償,金額合共約人民幣370萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.